FDA
.report
PMA
PMN
De Novo
MAUDE
GUDID
NDC
DailyMed
Drug Applications
FDA Letter JIANGSU PHARMS ANDA 214271
Letter
ANDA 214271
JIANGSU PHARMS
FDA.report
›
FDA Drug Approvals
›
JIANGSU PHARMS
›
ANDA 214271
›
Letter
Application #214271
Documents
Letter
2022-08-25
Application Sponsors
ANDA 214271
JIANGSU PHARMS
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.